Ozempic Users Report Sudden, Permanent Vision Loss. Now They’re Suing

A rare form of sudden and potentially permanent vision loss is becoming the latest safety question surrounding blockbuster GLP-1 drugs, with patients filing lawsuits in the U.S. even as regulators overseas have already added warnings. The condition is called nonarteritic anterior ischemic optic neuropathy, or NAION. It occurs when blood flow to the optic nerve is reduced, potentially causing abrupt vision loss that can be permanent.The complication appears to be extremely rare. The bigger issue is that researchers still disagree over whether drugs such as Ozempic and Wegovy actually cause it.That uncertainty is now moving from medical journals into courtrooms...